Burning Rock Biotech Ltd. (BNR)
US Market

Burning Rock Biotech Financial Statements

Burning Rock Biotech Financial Overview

Burning Rock Biotech's market cap is currently ―. The company's EPS TTM is ¥-1.325; its P/E ratio is -2.65; Burning Rock Biotech is scheduled to report earnings on August 16, 2022, and the estimated EPS forecast is ¥-0.27. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement
Total Revenue¥ 135.52M¥ 147.34M¥ 126.61M¥ 127.28M¥ 106.62M
Gross Profit¥ 87.58M¥ 105.38M¥ 91.60M¥ 90.23M¥ 76.94M
EBIT¥ -262.86M¥ -252.20M¥ -169.69M¥ -201.47M¥ -170.90M
EBITDA¥ -262.86M¥ -252.20M¥ -169.69M¥ -201.47M¥ -170.90M
Net Income Common Stockholders¥ -261.39M¥ -251.14M¥ -170.48M¥ -203.66M¥ -171.41M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments¥ 1.33B¥ 1.50B¥ 1.66B¥ 1.89B¥ 2.12B
Total Assets¥ 2.11B¥ 2.28B¥ 2.43B¥ 2.54B¥ 2.68B
Total Debt¥ 37.37M¥ 38.45M¥ 83.33M¥ 94.19M¥ 104.41M
Net Debt¥ -1.29B¥ -1.46B¥ -1.57B¥ -1.79B¥ -2.02B
Total Liabilities¥ 453.22M¥ 433.28M¥ 365.12M¥ 366.12M¥ 348.75M
Stockholders Equity¥ 1.65B¥ 1.85B¥ 2.06B¥ 2.17B¥ 2.33B
Cash Flow
Free Cash Flow¥ -144.36M¥ -325.80M¥ -133.39M¥ -119.00M¥ -113.14M
Operating Cash Flow¥ -144.36M¥ -112.35M¥ -133.39M¥ -119.00M¥ -113.14M
Investing Cash Flow¥ -13.01M¥ -66.97M¥ -72.08M¥ -67.58M¥ 288.33M
Financing Cash Flow¥ -3.93M¥ -6.78M¥ -32.99M¥ -8.96M¥ -4.16M
Currency in CNY

Burning Rock Biotech Earnings and Revenue History

Burning Rock Biotech Debt to Assets

Burning Rock Biotech Cash Flow

Burning Rock Biotech Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis